Summary: A genetic marker tied to human Restless Legs Syndrome (RLS) is essential for healthy cerebellar development. The team discovered that mutating the MEIS1 gene in zebrafish larvae destroys the animal’s rhythmic “burst and glide” locomotion, triggering hyperactive, extended movement cycles.
Neuro-imaging traced this behavior to a partial loss of Purkinje cells, the primary inhibitory neurons that regulate physical coordination. Human RLS medications reversed these symptoms in the fish, providing the first mechanistic proof of how an RLS risk gene disrupts motor pathways and pointing to the cerebellum as a primary target for future clinical research.
Key Facts
- The Primal Urge Dissected: RLS impacts millions globally, but its core neurobiological mechanisms have remained historically mysterious due to a lack of objective diagnostic biomarkers.
- Locomotion Shift: Mutant zebrafish lacking a functional MEIS1 gene lose their natural “burst and glide” swimming pattern, exhibiting hyperactive, continuous bursts of physical movement.
- Purkinje Cell Depletion: MEIS1 deficiency directly impairs cerebellar development, causing the degeneration and partial loss of Purkinje cells, the primary inhibitory neurons governing motor coordination.
- Loss of Motor Braking: Without functional Purkinje cell inhibition, downstream motor circuits over-fire, translating an internal neurological deficit into abnormal physical movement patterns.
- Pharmacological Validation: Standard human RLS medications successfully reversed the abnormal locomotor profiles in MEIS1 mutant fish, confirming the model’s clinical validity.
Source: University of Basel
Restless legs, restless nights: Restless Legs Syndrome (RLS) is a common but still mysterious sleep disorder. Using zebrafish, a team at the University of Basel has discovered that a gene associated with RLS is crucial for the development and function of the cerebellum. This may provide clues about the mechanisms that contribute to RLS symptoms.
An irresistible urge to move the legs or other areas, often accompanied by unpleasant sensations at night or during rest: Restless Legs Syndrome (RLS) affects millions of people worldwide. Despite being one of the most common sleep-related disorders, its biological causes remain poorly understood.
Researchers led by Professor Alex Schier at the Biozentrum of the University of Basel have discovered new clues about the underlying brain regions and mechanisms. Surprisingly, their findings come from an unlikely model organism: larval zebrafish.
“Studies in humans have implicated many different brain regions, but it remains unclear how they relate to RLS,” says Schier. “Our work highlights possible contributions from the cerebellum, a brain region crucial for coordinating movement.”
Genes and sleep disorders
The project originally started as a broader effort to understand the genetics of human sleep-related disorders, including RLS. “Previous studies identified genes associated with RLS symptoms in humans, but their neuronal and behavioral functions were unclear,” says Dr. William Joo, first author of the study.
Zebrafish with altered movement patterns
The researchers analyzed several genes, but one gene called MEIS1, immediately stood out. When this gene was mutated, the movement patterns of zebrafish larvae changed significantly.
Zebrafish larvae typically move in a “burst and glide” pattern – swimming, pausing, and swimming again. “In MEIS1 mutant zebrafish, bouts of movement became much longer,” says Joo.
“This prompted us to search for differences in brain activity or structure in the mutants.” Indeed, the researchers observed developmental abnormalities in the cerebellum of MEIS1 mutant zebrafish.
The cerebellum in focus
Particularly affected were the so-called Purkinje cells, prominent cerebellar neurons that suppress the activity of other neurons and help coordinate movement.
“This cell type is partially lost in the cerebellum of zebrafish mutants,” says Joo.
“Our results indicate that the activity of downstream neurons becomes perturbed when the Purkinje cells are missing, and that this is what generates abnormal locomotion patterns in the mutant larvae.” Furthermore, the researchers tested drugs commonly prescribed to treat RLS and found that these medications could normalize the behavior of mutant fish.
Clues for future therapies
This study is one of the first to mechanistically demonstrate how a gene linked to RLS affects both brain development and movement patterns and raises the possibility that other RLS risk genes may play similar roles. “Zebrafish have provided great insights into the functions of this RLS-related gene,” adds Schier. “But future studies must further investigate whether the same brain region and mechanisms are also relevant in RLS patients.”
These efforts may eventually support the development of more effective treatments and improve the diagnosis of RLS, which so far is based almost entirely on patient symptoms.
Key Questions Answered:
A: Despite their obvious structural differences from humans, zebrafish share a remarkably conserved genetic architecture and basic central nervous system blueprint with mammals, including similar neurotransmitter tracks and primitive sleep-wake networks. Larval zebrafish exhibit a highly distinct, easily quantified “burst and glide” movement pattern that is governed directly by core motor-coordination circuits. This readable behavior allows scientists to easily identify and isolate micro-fluctuations in movement driven by specific risk genes.
A: Purkinje cells are the major output neurons of the cerebellum, and their primary chemical job is inhibitory: they release GABA to turn down or quiet overactive signals in downstream motor pathways. Think of them as the neural braking system for physical motion. When the MEIS1 mutation causes a partial loss of these cells, the brain loses its capacity to suppress unnecessary motor impulses. Without these regulatory brakes, downstream neurons fire unchecked, generating hyperactive locomotion and continuous restlessness.
A: The team utilized pharmacological validation to bridge the gap between species. They administered standard, clinically approved human RLS medications directly to the MEIS1 mutant zebrafish larvae. Because these specific drugs successfully normalized the hyperactive swimming profiles of the mutant fish: restoring their natural resting and pacing intervals: it strongly suggests that the underlying chemical pathways being disrupted in the fish match the neuropharmacological mechanisms active in human RLS patients.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this genetics and neurology research news
Author: Angelika Jacobs
Source: University of Basel
Contact: Angelika Jacobs – University of Basel
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Disinhibition of cerebellar output by loss of Restless Legs Syndrome-associated gene MEIS1” by Joo W, Choi JW, Schier AF. Current Biology
DOI:10.1016/j.cub.2026.05.043
Abstract
Disinhibition of cerebellar output by loss of Restless Legs Syndrome-associated gene MEIS1
Genome-wide association studies have identified risk variants for restless legs syndrome (RLS), but the behavioral functions and sites of action of the corresponding genes remain unknown.
Here, we analyzed zebrafish mutants for candidate RLS genes and found that meis1b is required for normal locomotion behavior and cerebellar development.
Neuronal manipulation experiments indicated that loss of meis1b perturbs locomotor behavior by generating abnormal cerebellar output—a mechanism reminiscent of movement disorders such as ataxia and dystonia.
